FOX 47 - Health News
The Food and Drug Administration is on the verge of approving a new cancer vaccine.
In clinical trials, the vaccine helped prostate cancer patients live longer without the harsh side effects of chemo and radiation.
Doctors are quick to point out it's a vaccine only in name -- it's not preventative, it's not a cure -- but it may offer some hope.
Seattle-based Dendreon Corp. has developed a new cancer treatment -- a revolutionary cancer vaccine.
During treatment, doctors draw blood from a cancer patient, train the white blood cells to attack cancer cells, and inject them back into the body.
"This is a therapy targeting the immune system and then has your immune system target the cancer," said Dr. George Wilding, director of the UW Carbon Cancer Center.
Dr. Wilding says the UW served as one of the clinical trial locations for the vaccine. He says, unlike chemo, the vaccine does not destroy good cells in the body.
"This is entirely different that what has been used before," he said.
Studies show prostate cancer patients who took the vaccine lived, on average 4.5 months longer. Some men gained an extra two or three years of life.
"This would be a way to give hope to those people for whom other treatment options either wouldn't work or had not resulted in a cure," said Dr. D. Brooke Johnson, a urologist with Dean Health & St. Mary's Hospital.
Dr. Johnson says the vaccine is promising, but for most patients, it won't replace surgery, radiation, and chemotherapy. At least, he says, it's another option.
"It's a little too early to say if this will have long-term benefits for the general population with prostate cancer," he said.
So far, the only side effects of the vaccine are fevers and chills experienced by a few patients.
Doctors hope research with this prostate cancer vaccine will eventually help create vaccines for many kinds of cancers.
Prostate cancer kills about 30,000 men in United States every year.
Sun. - Fri. on FOX 47 News at 9!
Top Health Headlines (foxnews.com)
|Finding his voice: John Stossel details his struggles with stuttering|
It’s a medical mystery as old as speech itself that continues to stump scientists and medical professionals. Of the 3 million Americans who stutter, 4 out of 5 are males. One of them is Fox News’ own John Stossel
|MIT researchers discover possible 'vaccine' for PTSD|
It's a breakthrough that could help thousands of American soldiers returning from dangerous deployments. Researchers at the Massachusetts Institute of Technology believe they may have discovered a vaccine to prevent post-traumatic stress disorder.
|Consumers often confused about types of sugar in drinks|
Many Americans don't know how much and what kinds of sugar are in their beverages, according to a new study. But people who are concerned about sugar tend to be better at avoiding it, researchers found.
|Female libido drug remains in limbo|
The multi-decade search for a pill that boosts sexual desire in women has hit another roadblock, raising questions about the future of efforts to develop a female equivalent to Viagra.
|FDA to phase out some antibiotic use in animal production|
U.S. regulators announced new guidelines that call on global pharmaceutical companies to phase out the use of some antibiotics meant to enhance growth in animals used for food, hoping to stem a growing tide of bacterial resistance to the same drugs when they are prescribed for humans.
Tonight on FOX 47
5:00pm Two and a Half Men
5:30pm Big Bang Theory
6:00pm Modern Family
6:30pm Big Bang Theory
7:00pm The X Factor
9:00pm FOX 47 News at 9
9:35pm Modern Family
10:05pm The Arsenio Hall Show
11:05pm Two and a Half Men
12:05pm Everybody Loves Raymond